CNS Delivery Frontiers, Enabling Oligonucleotide Therapeutics for Neurological Disorders

By | 1 May 2026
  • Latest innovations in crossing the blood–brain barrier with oligonucleotide drugs
  • Design considerations for enabling safe and effective CNS delivery